XML 33 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2023
Feb. 23, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 000-26770    
Entity Registrant Name NOVAVAX, INC    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 22-2816046    
Entity Address, Address Line One 700 Quince Orchard Road,    
Entity Address, City or Town Gaithersburg,    
Entity Address, State or Province MD    
Entity Address, Postal Zip Code 20878    
City Area Code (240)    
Local Phone Number 268-2000    
Title of 12(b) Security Common Stock, Par Value $0.01 per share    
Trading Symbol NVAX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 699,000,000
Entity Common Stock, Shares Outstanding   139,953,143  
Documents Incorporated by Reference
Documents incorporated by reference: Portions of the Registrant’s Definitive Proxy Statement to be filed no later than 120 days after the fiscal year ended December 31, 2023 in connection with the Registrant’s 2024 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K to the extent indicated herein.
    
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001000694